Immunisation Coalition: Free flu vaccines
As part of Immunisation Action Week, the Immunisation Coalition will be running a free Influenza Vaccination Day in Melbourne, Sydney, Brisbane and Adelaide. In Melbourne, the free vaccine is available for people aged between 18 and 64 years. Walk-ins may be available on the day, but booking is recommended to secure a place.
Melbourne Vaccination Day:
Tuesday 30 April 2024 10 am–4 pm
Melbourne Town Hall , 90/130 Swanston Street, Melbourne 3000
Learn more and registered via the Immunisation Coalition’s event page.
ABC: Q fever case spike in Qld drives push for more accessible vaccine
As reported by ABC in March, Queensland has reported 89 Q fever infections since the beginning of 2024, an increase of almost 90% compared to the same time in 2023.
Q fever is caused by infection with the Coxiella burnetii bacteria. Bacterial reservoirs for human infection primarily include cattle, sheep, and goats; however, other animals can also be infected. Transmission occurs via the inhalation of infected aerosols or contaminated soil, dusts or water droplets.
The vaccine Q-Vax is recommended for those aged over 15 years in specific high-risk occupational groups. Q-Vax is available for private purchase. Researchers in Queensland are developing a new vaccine which they hope will be more accessible.
ABC: Q fever case spike in Qld drives renewed push for more accessible vaccine for ‘nasty’ bacterial disease (March 2024)
ABC: Q fever vaccine funding boosted as the hunt for a better solution continues (August 2020)
MVEC: Q fever
RSV programs announced in NSW and Qld
New South Wales and Queensland have both announced respiratory syncytial virus (RSV) programs to provide protection for infants and children.
In New South Wales, infants vulnerable to severe illness from RSV will be eligible to receive nirsevimab, a monoclonal antibody (available in Australia under the brand name Beyfortus). This includes:
- babies born before 37 weeks gestation and adter 31 October 2023
- Aboriginal and Torres Strait Islander babies born after 31 October 2023
- other infants living with specific chronic and complex health conditions.
Read more on the NSW Health website.
The Queensland program will also provide nirsevimab (brand name, Beyfortus) to eligible infants and young children, including:
- all newborn infants from birth
- Aboriginal and Torres Strait Islander infants up to < 8 months of age
- infants with certain complex medical conditions up to < 8 months of age
- young children with certain complex medical conditions from 8–19 months of age (until 31 October 2024).
For more details, read about the new program on the Queensland Health website.
Immunisation Coalition: 2024 Influenza webinar
The Immunisation Coalition will hold its 2024 Influenza webinar on Wednesday 3 April 2024, from 6:00 pm–7:00 pm.
This annual update is intended for GPs, nurse practitioners, pharmacists and other immunisation professionals. The webinar will be presented by Angela Newbound.
Learn more and register on the Immunisation Coalition event page.
AusVaxSafety Summary report 2022 published
Since 2014, AusVaxSafety has monitored the safety of all vaccines on the National Immunisation Program (NIP) and all COVID-19 vaccines used in Australia.
Surveillance is undertaken via a short vaccine safety survey which is sent to people (or their carers) who received their vaccine at a participating AusVaxSafety site across Australia. The surveys give participants the opportunity to report any adverse events following immunisation that they experienced and if they sought medical attention for any reason.
The Vaccine safety in Australia AusVaxSafety Summary report 2022 is now available on the Department of Health and Aged Care website.
Queensland Specialist Immunisation Service: Paediatric Immunisation Skills Workshop
Children’s Health Queensland’s Specialist Immunisation Service is hosting a Paediatric Immunisation Skills Workshop on 3 May 2024.
Topics to be covered include:
- comfort positioning and giving multiple vaccines
- procedural anxiety and distraction techniques
- vaccine hesitancy conversations
- the National Immunisation Program and catching up vaccination
- anaphylaxis, adverse events and reporting.
Read more and register.
NCIRS: New influenza resource
The टीकाकरण अनुसंधान और निगरानी के लिए राष्ट्रीय केंद्र (एनसीआईआरएस) has recently published a new Influenza reference page which includes influenza fact sheets and FAQs, vaccine coverage and safety data, and clinical/community resources.
NCRIS: Influenza immunisation
एमवीईसी: इन्फ्लुएंजा
Immunisation Coalition: 25th Annual Scientific Meeting conference recordings
The Immunisation Coalition’s 25th Annual Scientific Meeting was held from 4 to 5 February 2024.
The meeting was chaired by A/Prof Lou Irving from the Royal Melbourne Hospital and covered topics including Epidemiology of Infectious Diseases, Economics and Long-Term Implications of Vaccines, Primary Care and Vaccination, and Respiratory Virus Vaccines.
The Immunisation Coalition has published all the keynote presentations and sessions on their website. Presentations can be viewed on the Immunisation Coalition’s 25th Annual Scientific Meeting event page.
Immunisation Coalition: Influenza / COVID-19 / RSV webinar series
The Immunisation Coalition is hosting a series of 3 webinars on common vaccine-preventable respiratory viruses over the next three months, to be held on:
- 17 April 2024
- 22 May 2024
- 19 June 2024
These will include parent discussions on how the influenza, COVID-19 and RSV season is progressing and strategies around increasing vaccination rates.
Find out more and register on the Immunisation Coalition event page.
New episodes: The Vaccine Coverage
Today, MVEC released the fourth episode of our new podcast.
The most recent two episodes feature Prof Jim Buttery and Prof Nigel Crawford on the process of rolling out a vaccine, and Dr Linny Kimly Phuong on vaccines and the immune system. The podcast is tailored for an audience of both healthcare professionals and members of the general public.
Search ‘The Vaccine Coverage’ on your preferred podcast player, or listen via our website.
Once you have listened to the episodes, we would be grateful to get some feedback via this छोटा सर्वेक्षण.